Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02363153 · ClinicalTrials.gov registry record · NA
Diet and Exercise in Pompe Disease
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02363153: Completed NA study, sponsored by University of Florida.
NCT02363153 is a NA study that has completed, run by University of Florida. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02363153, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study examines the effects of individualized diet and exercise plans on muscle strength, quality of life and respiratory function in Pompe disease. Subjects will be given a diet and exercise plan based on their individual needs, which will be followed for 16 weeks. Participants will also be provided with an activity tracker in order to track their exercise activities, access to an app that will allow them to input their daily food intake, and they will also come to the University of Florida for exercise tests, respiratory tests and questionnaires.
Primary Outcome
The PROQOL assesses quality of life and health status to improve patient care
Interventions
- OTHER Diet and Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2021-05-12 |
| Phase | NA |
What the finished NCT02363153 record still lists
NCT02363153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Diet and Exercise is the first listed.
NCT02363153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02363153 about?
NCT02363153 is a clinical study titled "Diet and Exercise in Pompe Disease". This study examines the effects of individualized diet and exercise plans on muscle strength, quality of life and respiratory function in Pompe disease. Subjects will be given a diet and exercise plan based on their individual needs, which will be followed for 16 weeks. Participants will also be pro...
What is the current status of trial NCT02363153?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-11-06. Estimated completion is 2021-05-12.
What interventions are being tested in trial NCT02363153?
The interventions under investigation include: Diet and Exercise (OTHER).
Who is sponsoring clinical trial NCT02363153?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02363153's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI